Abstract: The present disclosure provides a composition and method for promoting functional neuronal development in pediatric subjects. The composition comprises in some embodiments up to about 7 g/100 Kcal of a fat or lipid source; up to about 5 g/100 Kcal of a protein source; about 3 mg/100 Kcal to about 50 mg/100 Kcal of phosphatidylethanolamine; about 0.15 mg/100 Kcal to about 75 mg/100 Kcal of sphingomyelin; and about 5 mg/100 Kcal to about 75 mg/100 Kcal of docosahexaenoic acid. The methods comprise, in some embodiments, administering the aforementioned composition to a pediatric subject.

Abstract: A method for enhancing neurological health and development in a subject involving administering to the subject a nutritional composition including no greater than about 7 g/100 kcal of a fat or lipid source; no greater than about 7 g/100 kcal of a protein or protein equivalent source; at least about 5 g/100 kcal of a carbohydrate; and at least about 9 mg/100 kcal of inositol, wherein the ratio of exogenous inositol to inherent inositol is at least 50:50.

Abstract: Fiber burning and/or overheating of the fiber feedthrough in high-power laser modules, which may cause catastrophic and/or collateral damage, may be addressed by providing an optical fiber assembly designed to withstand overheating due to errant high power laser light that is directed toward the input core of a fiber but may be at least partially misaligned. The optical fiber may be secured within a mount having a passageway such that the end face of the optical fiber extends past an opening of the passageway to a focal plane of the incident light. The end of the optical fiber may include a section that has a reduced or absent cladding layer (e.g., etched to form a tapered cladding region) so as to reduce the amount of light captured by the cladding and/or to leak the light out quickly.

Abstract: Provided herein are coatings for stem cell cultureware comprising poly-L-ornithine and bovine fibronectin and methods for preparing coated stem cultureware comprising contacting cultureware with poly-L-ornithine and contacting the cultureware with bovine fibronectin. Also provided are stem cell culture media comprising epidermal growth factor, beta-fibroblast growth factor and N2 supplement.

Abstract: A hardware interface component arranged to operably couple at least one arithmetic unit to a an interconnect component of a processing system. The hardware interface component comprises a plurality of program-visible registers and at least one operation decoder component. The at least one operation decoder component is arranged to, upon receipt of a write access request via the interconnect component corresponding to a decorated memory-mapped address range for the hardware interface component, decode a register identifier component of a target address of the received write access request to identify at least one of the program-visible registers, decode a decoration component of the target address of the received write access request to identify an arithmetic operation to be performed, and configure the arithmetic unit to perform the identified arithmetic operation on at least one input operand within the identified at least one program-visible register.

Abstract: Systems, methods, and computer-readable storage media for inter-node data replication while reducing network traffic for remote backup. A system receives a command to duplicate a dataset, located on a source network node, to a remote network node, accesses, on the source network node, signatures of a previous snapshot of the dataset and signatures of a current snapshot of the dataset, performs, at the source network node, a local signature comparison between the previous snapshot and the current snapshot to identify one or more signatures that do not match, sends the signatures that do not match to the remote network node, searches, on the remote network node, for the signatures that do not match, and sends data associated with the signatures that do not match to the remote network node for incorporation within a current remote snapshot if they do not exist on a current remote network node.

Abstract: Provided herein are methods for detecting and/or confirming the neurogenesis effect of cholesterol and/or oxysterol utilizing adipose-derived stem cells (ADSCs). Further provided are methods of promoting neurogenesis in ADSCs. Also provided are methods for the use of cholesterol and/or oxysterol for the production of a neurologic component that may be incorporated into a nutritional composition for promoting neurogenesis in a pediatric subject.

Abstract: Fiber burning and/or overheating of the fiber feedthrough in high-power laser modules, which may cause catastrophic and/or collateral damage, may be addressed by providing an optical fiber assembly designed to withstand overheating due to errant high power laser light that is directed toward the input core of a fiber but may be at least partially misaligned. The optical fiber may be secured within a mount having a passageway such that the end face of the optical fiber extends past an opening of the passageway to a focal plane of the incident light. The end of the optical fiber may include a section that has a reduced or absent cladding layer (e.g., etched to form a tapered cladding region) so as to reduce the amount of light captured by the cladding and/or to leak the light out quickly.

Abstract: The present disclosure is directed to methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising a neurologic component, wherein the neurologic component may promote brain and nervous system development and further provide neurological protection and repair. The neurologic component may include lactoferrin, zinc sulfate, one or more organosulfur compounds, and mixtures thereof.

Abstract: Disclosed are methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising docosahexaenoic acid and alpha-lipoic acid. The nutritional composition may further include lactoferrin, a prebiotic, a probiotic, and mixtures thereof. Additionally disclosed are methods for accelerating the development of neuronal activity and/or strengthening electrochemical synapse signaling by providing the nutritional composition(s) disclosed herein to a target subject.

Abstract: A demodulator suitable for demodulating binary FSK signals having a small difference between carrier frequencies uses a counter-timer technique for timing a fixed number FSK cycles and comparing a count value with a threshold when a frequency change is expected. By grouping a number of FSK pulses (or cycles) together in one measurement, speed requirements on the system clock used for the counter/timer measurements can be relaxed and tolerance to noise is also improved. The demodulator is particularly suitable for wireless charging applications.

Abstract: The present disclosure generally relates to nutritional compositions that are suitable for administration to adult and pediatric subjects that include ursolic acid, and advantageously provide beneficial health effects such as enhanced brain development and improved memory, cognition, hand-eye coordination, and enhanced focusing. Furthermore, the ursolic acid may act synergistically with other brain nutrients that may be present in the compositions.

Abstract: A true random number generator (RNG) has one or more oscillators and an output register for storing a random number output. Each of the oscillators is activated, successively, in a free-running oscillation phase, and a capture phase during which the oscillator is quiescent. The output register latches during the capture phase of each oscillator an end state of that oscillator at or close to the end of its oscillation phase. The random number output is derived from the latched end states.

Abstract: The present disclosure relates to methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising a neurologic component, wherein the neurologic component may promote brain and nervous system development and further provide neurological protection and repair. The neurologic component may include lactoferrin, zine sulfate, one or more organosulfur compound, and mixtures thereof.

Abstract: The present disclosure relates to methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising docosahexaenoic acid and alpha-lipoic acid. The nutritional composition may further include lactoferrin, a prebiotic, a probiotic, and mixtures thereof. Additionally the present disclosure provides methods for accelerating the development of neuronal activity and/or strengthening electrochemical synapse signaling by providing the nutritional composition(s) disclosed herein to a target subject.

Abstract: Techniques for presenting patient data at the patient's bedside include receiving predetermined presentation style data that indicates a subset of fewer than all parameters available from an electronic medical records (EMR) system and a first arrangement on a display device of related parameters in the subset. Without human intervention, the most recent values from the EMR system are received. The most recent values are associated in the EMR system with the particular patient for corresponding parameters of the subset. A first most recent value is presented according to the first arrangement at the particular bedside display device without human intervention. In some embodiments, the most recent values are also received or presented in response to a single stroke from a human user at an input for the particular display device.

Abstract: The present disclosure relates to nutritional compositions comprising a neurologic component, wherein, the neurologic component may promote brain and nervous system development and further provide neurological protection and repair. The neurologic component may include phosphatidylethanolamine, sphingomyelin, cytidine diphosphate-choline, ceramide, uridine, at least one ganglioside, and mixtures thereof. The disclosure further relates to methods of promoting brain and nervous system health by providing said nutritional compositions to target subjects, which includes pediatric subjects.

Abstract: This invention is in the fields of immunology and autoimmunity. More particularly it concerns pharmaceutical compositions comprising compounds which are useful agents for inhibiting the functions of TIP60 and the use of such compounds in the treatment of an individual suffering, for example, from ulcerative colitis and other irritable bowel diseases.

Abstract: Provided herein are methods for detecting and/or confirming the neurogenesis effect of cholesterol and/or oxysterol utilizing adipose-derived stem cells (ADSCs). Further provided are methods of promoting neurogenesis in ADSCs. Also provided are methods for the use of cholesterol and/or oxysterol for the production of a neurologic component that may be incorporated into a nutritional composition for promoting neurogenesis in a pediatric subject.

Abstract: Provided herein are methods for detecting and/or confirming the neurogenesis effect of eicosapentaenoic acid utilizing adipose-derived stem cells (ADSCs). Further provided are methods of promoting neurogenesis in ADSCs. Also provided are methods for the use of eicosapentaenoic acid for the production of a neurologic component that may be incorporated into a nutritional composition for promoting neurogenesis in a pediatric subject.